Literature DB >> 15930293

BRCA2 suppresses cell proliferation via stabilizing MAGE-D1.

Xin-xia Tian1, Deepak Rai, Jun Li, Chaozhong Zou, Yujie Bai, David Wazer, Vimla Band, Qingshen Gao.   

Abstract

Germ line mutations in BRCA2 gene predispose women to early-onset familial breast and ovarian cancer. BRCA2 is a protein of multiple functions. In addition to its role in DNA double-strand break repair, BRCA2 also plays a role in stabilization of stalled DNA replication forks, cytokinesis, transcription regulation, mammalian gametogenesis, centrosome duplication, and suppression of cell proliferation. However, how BRCA2 mutations predispose women specifically to breast and ovarian cancer remains undefined. Here we found that BRCA2 binds and stabilizes MAGE-D1, a member of the MAGE gene family of proteins. Expression of BRCA2 and MAGE-D1 synergistically suppresses cell proliferation independently of the p53 pathway. Using two MAGE-D1 RNA interferences and two cell lines expressing low or undetectable levels of MAGE-D1, we further showed that the expression of MAGE-D1 is required for BRCA2-mediated suppression of cell proliferation, indicating that MAGE-D1 is a downstream target of BRCA2 and that BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Importantly, MAGE-D1 protein expression was reduced in 6 of 16 breast carcinoma cell lines tested as compared with untransformed immortal mammary epithelial cell lines, suggesting that suppression of MAGE-D1 expression may be involved in the tumorigenesis of a subset of sporadic breast cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930293      PMCID: PMC3295243          DOI: 10.1158/0008-5472.CAN-05-0018

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.

Authors:  Aya Sasaki; Yoshiko Masuda; Kazuhiro Iwai; Kyoji Ikeda; Ken Watanabe
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

2.  Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death.

Authors:  B W Jordan; D Dinev; V LeMellay; J Troppmair; R Gotz; L Wixler; M Sendtner; S Ludwig; U R Rapp
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

3.  UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE.

Authors:  Megan E Williams; Phyllis Strickland; Ken Watanabe; Lindsay Hinck
Journal:  J Biol Chem       Date:  2003-02-21       Impact factor: 5.157

4.  Inhibition of cancer cell growth by BRCA2.

Authors:  Shao-Chun Wang; Ruping Shao; Annie Y Pao; Su Zhang; Mien-Chie Hung; Li-Kuo Su
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

Review 5.  The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease.

Authors:  Philip A Barker; Amir Salehi
Journal:  J Neurosci Res       Date:  2002-03-15       Impact factor: 4.164

6.  BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.

Authors:  Haijuan Yang; Philip D Jeffrey; Julie Miller; Elspeth Kinnucan; Yutong Sun; Nicolas H Thoma; Ning Zheng; Phang-Lang Chen; Wen-Hwa Lee; Nikola P Pavletich
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

7.  EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.

Authors:  Luke Hughes-Davies; David Huntsman; Margarida Ruas; Francois Fuks; Jacqueline Bye; Suet-Feung Chin; Jonathon Milner; Lindsay A Brown; Forrest Hsu; Blake Gilks; Torsten Nielsen; Michael Schulzer; Stephen Chia; Joseph Ragaz; Anthony Cahn; Lori Linger; Hilal Ozdag; Elena Cattaneo; E S Jordanova; Edward Schuuring; David S Yu; Ashok Venkitaraman; Bruce Ponder; Aidan Doherty; Samuel Aparicio; David Bentley; Charles Theillet; Chris P Ponting; Carlos Caldas; Tony Kouzarides
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

8.  Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.

Authors:  Shobbir Hussain; Emily Witt; Pia A J Huber; Annette L Medhurst; Alan Ashworth; Christopher G Mathew
Journal:  Hum Mol Genet       Date:  2003-08-05       Impact factor: 6.150

9.  Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.

Authors:  Luca Pellegrini; David S Yu; Thomas Lo; Shubha Anand; MiYoung Lee; Tom L Blundell; Ashok R Venkitaraman
Journal:  Nature       Date:  2002-11-10       Impact factor: 49.962

10.  The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution.

Authors:  Takeru Matsuda; Hiroaki Suzuki; Isao Oishi; Shuichi Kani; Yoshikazu Kuroda; Takahide Komori; Aya Sasaki; Ken Watanabe; Yasuhiro Minami
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

View more
  16 in total

1.  Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Authors:  Arnaldo A Arbini; Margherita Greco; Jorge L Yao; Patricia Bourne; Ersilia Marra; Jer-Tsong Hsieh; Paul A di Sant'agnese; Loredana Moro
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.

Authors:  Smita Misra; Shvetank Sharma; Anupriya Agarwal; Sheetal V Khedkar; Manish K Tripathi; Mukul K Mittal; Gautam Chaudhuri
Journal:  Mol Cancer       Date:  2010-03-04       Impact factor: 27.401

3.  Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma.

Authors:  Ryan N Serio
Journal:  Cancer Microenviron       Date:  2011-11-23

4.  The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients.

Authors:  Yousri M Hussein; Amal F Gharib; Rasha L Etewa; Amal S El-Shal; Mohamed Esmat Abdel-Ghany; Wael H Elsawy
Journal:  Mol Cell Biochem       Date:  2011-01-25       Impact factor: 3.396

5.  Nodal and activin receptor-like kinase 7 induce apoptosis in human breast cancer cell lines: Role of caspase 3.

Authors:  Yu Zhong; Guoxiong Xu; Gang Ye; Daniel Lee; Joseph Modica-Amore; Chun Peng
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-02-27

6.  Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration.

Authors:  Tuan H N Nguyen; Mathieu J M Bertrand; Christiane Sterpin; Younes Achouri; Olivier R Y De Backer
Journal:  BMC Cell Biol       Date:  2010-07-20       Impact factor: 4.241

Review 7.  Complex roles of NRAGE on tumor.

Authors:  Ge Zhang; Huandi Zhou; Xiaoying Xue
Journal:  Tumour Biol       Date:  2016-05-21

8.  Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort.

Authors:  Tryggvi Thorgeirsson; Kristina M Jordahl; Richard Flavin; Mara Meyer Epstein; Michelangelo Fiorentino; Swen-Olof Andersson; Ove Andren; Jennifer R Rider; Juan Miguel Mosquera; Helen Ingoldsby; Katja Fall; Laufey Tryggvadottir; Lorelei A Mucci
Journal:  Carcinogenesis       Date:  2016-01-16       Impact factor: 4.944

9.  Maged1 co-interacting with CREB through a hexapeptide repeat domain regulates learning and memory in mice.

Authors:  JianJun Yang; BeiBei Lai; AiLi Xu; Yu Liu; XiaoMin Li; YongNa Zhao; WeiFeng Li; MuHuo Ji; Gang Hu; Xiang Gao; Jun Gao
Journal:  Mol Neurobiol       Date:  2014-04-04       Impact factor: 5.590

10.  Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.

Authors:  Abhirami Radhakrishnan; Nirmala Badhrinarayanan; Jyotirmay Biswas; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2009-10-22       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.